Real-time, once-daily monitoring of symptoms and FEV1 in cystic fibrosis patients - A feasibility study using a novel device

被引:28
作者
Sarfaraz, Sunny [1 ]
Sund, Zoe [1 ]
Jarad, Nabil [1 ]
机构
[1] Bristol Royal Infirm & Gen Hosp, Dept Resp Med, Adult CF Ctr, Bristol BS2 8HW, Avon, England
关键词
cystic fibrosis; electronic daily monitoring; pulmonary exacerbation; QUALITY-OF-LIFE; PULMONARY EXACERBATIONS; THERAPY; PROGRAM; DISEASE; IMPACT;
D O I
10.1111/j.1752-699X.2009.00147.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and Aims: We investigated feasibility and value of a real-time electronic monitoring system adapted for early detection of cystic fibrosis (CF) pulmonary exacerbations (P Exs). Methods: This was a 6-month prospective study. Patients recorded once daily their symptom score and spirometry using an electronic diary. The data were sent daily to the research team in real time. P Ex was considered to be present when change in symptoms and lung function values met a preset criteria. Number of P Exs during the study was compared with a parallel period of the previous and of the following years. Results: Only 19 patients (37.2%) completed recording that could be evaluated. A total of 53 P Exs were identified, 26 (49.0%) of which needed intravenous (IV) antibiotics. The number of total P Exs in the study year did not differ from the previous or the following year, but the number of courses of oral antibiotics was greater than those given during the previous year. Conclusion: Remote daily monitoring of symptoms and spirometry had a poor uptake among CF patients. For those who completed the study, this method early detected P Exs that were treated with oral antibiotics that might otherwise required IV antibiotics. Please cite this paper as: Sarfaraz S, Sund Z and Jarad N. Real-time, once-daily monitoring of symptoms and FEV1 in cystic fibrosis patients - A feasibility study using a novel device. The Clinical Respiratory Journal 2010; 4: 74-82.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 25 条
[1]  
[Anonymous], 1994, RESP MED, V88, P165
[2]   Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis [J].
Britto, MT ;
Kotagal, UR ;
Hornung, RW ;
Atherton, HD ;
Tsevat, J ;
Wilmott, RW .
CHEST, 2002, 121 (01) :64-72
[3]  
BROWNEWING LJ, 1988, MED INSTRUM, V22, P240
[4]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[5]  
*CYST FIBR FDN, 1994, MICR INF DIS CYST FI, V5
[6]   Defining an exacerbation of pulmonary disease in cystic fibrosis [J].
Dakin, C ;
Henry, RL ;
Field, P ;
Morton, J .
PEDIATRIC PULMONOLOGY, 2001, 31 (06) :436-442
[7]   Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [J].
Donaldson, GC ;
Seemungal, TAR ;
Bhowmik, A ;
Wedzicha, JA .
THORAX, 2002, 57 (10) :847-852
[8]  
Doring Gerd, 2004, J Cyst Fibros, V3, P67, DOI 10.1016/j.jcf.2004.03.008
[9]   THE IMPACT OF HOME MONITORING AND DAILY DIARY RECORDING ON PATIENT STATUS IN CYSTIC-FIBROSIS [J].
FINKELSTEIN, SM ;
WIELINSKI, CL ;
KUJAWA, SJ ;
LOEWENSON, R ;
WARWICK, WJ .
PEDIATRIC PULMONOLOGY, 1992, 12 (01) :3-10
[10]   FEASIBILITY AND COMPLIANCE STUDIES OF A HOME MEASUREMENT MONITORING PROGRAM FOR CYSTIC-FIBROSIS [J].
FINKELSTEIN, SM ;
BUDD, JR ;
WARWICK, WJ ;
KUJAWA, SJ ;
WIELINSKI, CL ;
EWING, LB .
JOURNAL OF CHRONIC DISEASES, 1986, 39 (03) :195-205